The FDA recently granted NuVasive 510(k) clearance to expand its CoRent Small Interlock system for multilevel use in cervical spine surgery.
Four insights:
1. The CoRent device is now expanded for use at multiple adjacent levels from C2-T1 for anterior cervical discectomy and fusion procedures.
2. The device is an anterior cervical interbody fusion system intended for use in patients suffering from cervical disc degeneration and/or cervical spinal instability.
3. It is a no-profile interfixated interlock system that is implanted within the vertebral disc.
4. CoRent features a zero-step locking mechanism, a large fusion space, angled instrumentation for difficult implantation areas and a three-screw design that improves interbody placement.
More articles on devices:
19 spine devices receive FDA 510(k) clearance in October
Medtronic Q2 spine revenue up 5.5%
Orthofix M6-C cervical disc in 2019: 7 key developments